Botmindichtheidsmeting

Botmindichtheidsmeting, also known as bone mineral density (BMD) measurement, is a medical diagnostic procedure used to assess the strength of a person's bones. It is most commonly used to diagnose osteoporosis, a condition characterized by weakened bones that are more susceptible to fractures. The measurement determines the amount of bone mineral in a given volume of bone.

The most widely used method for botmindichtheidsmeting is dual-energy X-ray absorptiometry (DXA or DEXA). This technique uses two different X-ray beams to measure bone density. DXA scans are quick, painless, and involve minimal radiation exposure. They are typically performed on the hip and spine, as these are common sites for osteoporotic fractures. Other methods include quantitative computed tomography (QCT) and peripheral DXA (pDXA), which may be used in specific circumstances.

The results of a botmindichtheidsmeting are expressed as T-scores and Z-scores. A T-score compares a patient's bone density to that of a healthy young adult of the same sex. A Z-score compares the patient's bone density to that of individuals of the same age, sex, and ethnicity. These scores help physicians determine the risk of fracture and guide treatment decisions.

Botmindichtheidsmeting is recommended for individuals at higher risk of osteoporosis, including postmenopausal women, men over 70, individuals with a history of fractures, and those with certain medical conditions or taking specific medications. Early detection and treatment can help prevent fractures and maintain bone health.